Drug recall · November 20, 2019
Rite Aid Pharmacy Maximum Strength Ranitidine Tablets recall
Why: GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rite Aid Pharmacy Maximum Strength Ranitidine Tablets, USP 150 mg-acid reducer Distributed By: Rite Aid 30 Hunter Lane Camp Hill, PA 17011 a) 50 tablets NDC 11822-6052-1; b) 65 tablets NDC 11822-6052-2; c) 95 tablets NDC 11822-4727-3; d) 24 tablets NDC 11822-6051-8
- Lots / codes
All lots remaining within expiry.
- Quantity
- 215,387 bottles
- Company
- Apotex Inc., North York, N/A
- Distribution
- Nationwide
- Initiated
- September 24, 2019 · Voluntary: Firm initiated
- Classified
- November 12, 2019
- Reported
- November 20, 2019
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ranitidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.